In last trading session, HCW Biologics Inc (NASDAQ:HCWB) saw 1.52 million shares changing hands with its beta currently measuring 0.82. Company’s recent per share price level of $0.26 trading at -$0.06 or -20.03% at ring of the bell on the day assigns it a market valuation of $9.80M. That closing price of HCWB’s stock is at a discount of -869.23% from its 52-week high price of $2.52 and is indicating a discount of -7.69% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.19 million shares which gives us an average trading volume of 9.74 million if we extend that period to 3-months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
Upright in the red during last session for losing -20.03%, in the last five days HCWB remained trading in the red while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $0.26 price level, adding 27.78% to its value on the day. HCW Biologics Inc’s shares saw a change of -41.92% in year-to-date performance and have moved -23.79% in past 5-day. HCW Biologics Inc (NASDAQ:HCWB) showed a performance of -38.01% in past 30-days. Number of shares sold short was 8092.0 shares which calculate 0.28 days to cover the short interests.
HCW Biologics Inc (HCWB) estimates and forecasts
This year revenue growth is estimated to rise 222.75% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 7M for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -34.57% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 18.57% while estimates for its earnings growth in next 5 years are of 8.29%.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
Insiders are in possession of 52.30% of company’s total shares while institution are holding 3.13 percent of that, with stock having share float percentage of 6.56%. Investors also watch the number of corporate investors in a company very closely, which is 3.13% institutions for HCW Biologics Inc that are currently holding shares of the company. AVANTAX PLANNING PARTNERS, INC. is the top institutional holder at HCWB for having 0.28 million shares of worth $0.18 million. And as of 2024-06-30, it was holding 0.751 of the company’s outstanding shares.
The second largest institutional holder is HIGHTOWER ADVISORS, LLC, which was holding about 0.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.4857 of outstanding shares, having a total worth of $0.12 million.
On the other hand, Fidelity Extended Market Index Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 95.21 shares of worth $24668.0 or 0.25% of the total outstanding shares. The later fund manager was in possession of 84.7 shares on Sep 30, 2024 , making its stake of worth around $21945.0 in the company or a holder of 0.22% of company’s stock.
